Anemia Among Long-Term Renal Transplant Recipients

Transplantation Proceedings

Volumn 40, Issue 1, 2008, Pages 186-188

  Ghafari, A ^a   Noori Majelan, N ^b  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b YAZD UNIVERSITY   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; HEMOGLOBIN; IRON; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RECOMBINANT ERYTHROPOIETIN; STEROID; TRANSFERRIN;

ADULT; ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; CHRONIC INFLAMMATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON DEFICIENCY; KIDNEY TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; OUTPATIENT CARE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; TRANSFERRIN BLOOD LEVEL;

ADULT; ANEMIA; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBINS; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SEX CHARACTERISTICS;

EID: 38749152423     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.12.004     Document Type: Article

References (13)

1. Foley R.N., Parfrey P.S., Harnett J.D., et al. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 28 (1996) 53
2. Holland D.C., and Lam M. Predictors of hospitalization and death among pre-dialysis patients: a retrospective cohort study. Nephrol Dial Transplant 15 (2000) 650
3. Hayashi T., Suzuki A., Shoji T., et al. Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. Am J Kidney Dis 35 (2000) 250
4. United States Renal Data System: Annual Data Report 1999 (1999) Bethesda, Md
5. Vanrenterghem Y., Ponticelli C., Morales J.M., et al. Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant 3 (2003) 835
6. Mix T.C., Kazmi W., Khan S., et al. Anemia: a continuing problem following kidney transplantation. Am J Transplant 3 (2003) 1426
7. Lorenz M., Kletzmayr J., Perschl A., et al. Anemia and iron deficiencies among long-term renal transplant recipients. J Am Soc Nephrol 13 (2002) 794
8. Kalantar-Zadeh K., Rodriguez R.A., and Humphreys M.H. Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients. Nephrol Dial Transplant 19 (2004) 141
9. National Kidney Foundation. K/DOQI clinical practice guidelines for kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39 suppl 1 (2002) 1
10. Kasiske B.L., Vazquez M.A., Harmon W.E., et al. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 11 suppl 15 (2000) S1
11. Yorgin P.D., Scandling J.D., Belson A., et al. Late post-transplant anemia in adult renal transplant recipients. An underrecognized problem?. Am J Transplant 2 (2002) 429
12. Zazgornik J. Azathioprine induced macrocytosis and red cell aplasia in renal transplant patients. Nephrol Dial Transplant 12 (1997) 628
13. European Mycophenolate Mofetil Cooperative Study Group. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 345 (1995) 1321